Literature DB >> 17097056

Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy.

Jeanne L Theis1, J Martijn Bos, Virginia B Bartleson, Melissa L Will, Josepha Binder, Matteo Vatta, Jeffrey A Towbin, Bernard J Gersh, Steve R Ommen, Michael J Ackerman.   

Abstract

Hypertrophic cardiomyopathy (HCM) can be classified into at least four major anatomic subsets based upon the septal contour, and the location and extent of hypertrophy: reverse curvature-, sigmoidal-, apical-, and neutral contour-HCM. Here, we sought to identify genetic determinants for sigmoidal-HCM and hypothesized that Z-disc-HCM may be associated preferentially with a sigmoidal phenotype. Utilizing PCR, DHPLC, and direct DNA sequencing, we performed mutational analysis of five genes encoding cardiomyopathy-associated Z-disc proteins. The study cohort consisted of 239 unrelated patients with HCM previously determined to be negative for mutations in the eight genes associated with myofilament-HCM. Blinded to the Z-disc genotype status, the septal contour was graded qualitatively using standard transthoracic echocardiography. Thirteen of the 239 patients (5.4%) had one of 13 distinct HCM-associated Z-disc mutations involving residues highly conserved across species and absent in 600 reference alleles: LDB3 (6), ACTN2 (3), TCAP (1), CSRP3 (1), and VCL (2). For this subset with Z-disc-associated HCM, the septal contour was sigmoidal in 11 (85%) and apical in 2 (15%). While Z-disc-HCM is uncommon, it is equal in prevalence to thin filament-HCM. In contrast to myofilament-HCM, Z-disc-HCM is associated preferentially with sigmoidal morphology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097056     DOI: 10.1016/j.bbrc.2006.10.119

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

2.  Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands.

Authors:  I Christiaans; E A Nannenberg; D Dooijes; R J E Jongbloed; M Michels; P G Postema; D Majoor-Krakauer; A van den Wijngaard; M M A M Mannens; J P van Tintelen; I M van Langen; A A M Wilde
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

3.  Deletion of Drosophila muscle LIM protein decreases flight muscle stiffness and power generation.

Authors:  Kathleen A Clark; Heather Lesage-Horton; Cuiping Zhao; Mary C Beckerle; Douglas M Swank
Journal:  Am J Physiol Cell Physiol       Date:  2011-05-11       Impact factor: 4.249

Review 4.  Inherited cardiomyopathies.

Authors:  Jeffrey A Towbin
Journal:  Circ J       Date:  2014-09-02       Impact factor: 2.993

Review 5.  Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.

Authors:  Andrew P Landstrom; Michael J Ackerman
Journal:  Circulation       Date:  2010-12-07       Impact factor: 29.690

Review 6.  Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.

Authors:  Babken Asatryan; Argelia Medeiros-Domingo
Journal:  J Mol Med (Berl)       Date:  2018-08-20       Impact factor: 4.599

7.  ACTN2 mutations cause "Multiple structured Core Disease" (MsCD).

Authors:  Xavière Lornage; Norma B Romero; Claire A Grosgogeat; Edoardo Malfatti; Sandra Donkervoort; Michael M Marchetti; Sarah B Neuhaus; A Reghan Foley; Clémence Labasse; Raphaël Schneider; Robert Y Carlier; Katherine R Chao; Livija Medne; Jean-François Deleuze; David Orlikowski; Carsten G Bönnemann; Vandana A Gupta; Michel Fardeau; Johann Böhm; Jocelyn Laporte
Journal:  Acta Neuropathol       Date:  2019-01-30       Impact factor: 17.088

Review 8.  "Z"eroing in on the role of Cypher in striated muscle function, signaling, and human disease.

Authors:  Farah Sheikh; Marie-Louise Bang; Stephan Lange; Ju Chen
Journal:  Trends Cardiovasc Med       Date:  2007-11       Impact factor: 6.677

9.  Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.

Authors:  Christopher J McLeod; J Martijn Bos; Jeanne L Theis; William D Edwards; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Am Heart J       Date:  2009-10-03       Impact factor: 4.749

10.  Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy.

Authors:  J Martijn Bos; Jeanne L Theis; A Jamil Tajik; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Am Heart J       Date:  2008-02-21       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.